IQV vs VXRT · P/E 23, rev $15.40B vs rev $28.7M
IQVIA Holdings Inc (IQV) versus Vaxart Inc (VXRT) — a side-by-side from cached financials, not a winner call.
IQVIA Holdings Inc (IQV) is a diagnostics & research company listed on US.
Vaxart Inc (VXRT) is a biotechnology company listed on US.
Latest reported IQV revenue for 2024-12-31 was $15.40B. Net income was $1.37B. Revenue was up 2.8% from 2023-12-31 to 2024-12-31. IQV currently screens at market cap $30.62B and trailing P/E 22.8.
Latest reported VXRT revenue for 2024-12-31 was $28.7M. Net income was -$66.9M. Revenue was up 288.9% from 2023-12-31 to 2024-12-31. VXRT currently screens at market cap $73.0M.
IQV currently screens at market cap $30.62B and trailing P/E 22.8. VXRT currently screens at market cap $73.0M.
Not investment advice. Open the IQV and VXRT stock pages for the full models.
Not investment advice.